TrialTargeted oncology2022

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.

Michelino De Laurentiis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.